TITLE

HEADACHE, ANTIPHOSPHOLIPID ANTIBODIES AND CEREBRAL ISCHEMIA IN PATIENTS WITH SYSTEMIC IMMUNE-MEDIATED DISEASES

AUTHOR(S)
Tanasescu, R.; Nicolau, Adriana; Ticmeanu, Marina; Cojocaru, Inimioara; Ene, Amalia; Caraiola, Simona; Ionescu, R.; Baicus, C.
PUB. DATE
June 2007
SOURCE
Romanian Journal of Neurology;Jun2007, Vol. 6 Issue 2, p71
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The antiphospholipid syndrome (APS) is defined by the constant presence of antiphospholipid antibodies (aPL), together with diverse systemic clinical manifestations such as thrombosis, and recurrent spontaneous abortions. By the actual classification criteria, the only neurological manifestation diagnostic of APS is ischemic stroke. However, other neurological manifestations have been repeatedly reported in case studies of APS patients. Among these manifestations, headache and especially migraine was commonly reported in APS patients and is one of the classical features described by Hughes as related to aPL. However, controversies were raised by studies who failed to confirm this association. We studied the association between aPL and headache syndromes in a retrospective manner in 428 patients with inflammatory connective tissue diseases. We found that migraine alone, not headache all types, is significantly associated with aPL in patients with systemic immune disease. The presence of cerebral ischemia was also studied in patients with headache and aPL. In SLE patients, headache (all types) is significantly associated with positive titers of aPL, and cerebral ischemic lesions are significantly encountered. Even that the association migraine - aPL can be explained also by their separate high frequency in patients with immune systemic disease, the association of ischemic lesions in these patients suggest the need to define a sub-group at risk, for whom headache can be a marker and anticoagulants can be discussed.
ACCESSION #
27745754

 

Related Articles

  • Antiphospholipid syndrome. Keswani, Sanjay C.; Chauhan, Naresh // Journal of the Royal Society of Medicine;Jul2002, Vol. 95 Issue 7, p336 

    The article offers information about the antiphospholipid syndrome (APS). Thrombosis, recurrent fetal death and the presence of circulating antiphospholipid antibodies characterized APS. It can be in a primary form, with no associated systemic disease, and a secondary form, in which systemic...

  • The Antiphospholipid Syndrome. Levine, Jerrold S.; Branch, D. Ware; Rauch, Joyce // New England Journal of Medicine;3/7/2002, Vol. 346 Issue 10, p752 

    Discusses the 'antiphospholipid syndrome,' which was first coined to denote the clinical association between antiphospholipid antibodies, a family of autoantibodies, and a syndrome of hypercoagulability. Diagnosis; Pathogenesis; Epidemiology; Pathological features; Obstetrical considerations;...

  • Primary anetoderma: a cutaneous sign of antiphospholipid antibodies. Hodak, E; Feuerman, H; Molad, Y; Monselise, Y; David, M // Lupus;2003, Vol. 12 Issue 7, p564 

    Although a few reports in recent years have suggested that patients with antiphospholipid antibodies (aPL) are prone to developing primary anetoderma (PA), it is still unclear how often aPL are detected in unselected PA patients. We studied nine consecutive PA patients for the presence of...

  • High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. de Larrañaga, G.F.; Forastiero, R.R.; Martinuzzo, M.E.; Carreras, L.O.; Tsariktsian, G.; Sturno, M.M.; Alonso, B.S. // Lupus;2000, Vol. 9 Issue 8, p594 

    Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates that β[sub 2] glycoprotein I (β[sub 2]GPI) and prothrombin are the main proteins to which autoimmune aPL bind. The aim of this...

  • Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Ramos-Casals, M.; Campoamor, M.T.; Chamorro, A.; Salvador, G.; Segura, S.; Botero, J. C.; Yag�e, J.; Cervera, R.; Ingelmo, M.; Font, J. // Lupus;2004, Vol. 13 Issue 10, p777 

    The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its association with the main clinical,...

  • ANTIPHOSPHOLIPID SYNDROME.  // Current Medical Literature: Rheumatology;2005, Vol. 24 Issue 2, p42 

    This article focuses on various studies related to antiphospholipid syndrome. One article is "Livedo Reticularis and Pregnancy Morbidity in Patients Negative for Antiphospholipid Antibodies," by S. Sangle, D.P. D'Cruz, and G.R. Hughes. This article is a concise report that emphasizes the...

  • Platelets and the antiphospholipid syndrome. Urbanus, R. T.; Derksen, R. H. W. M.; de Groot, P. G. // Lupus;Oct2008, Vol. 17 Issue 10, p888 

    The antiphospholipid syndrome is a non-inflammatory autoimmune disease characterised by the presence of antiphospholipid antibodies in the plasma of patients with venous or arterial thrombosis or recurrent complications of pregnancy. The strong relation between the presence of antibodies against...

  • Co-existing sarcoidosis, systemic lupus erythematosus and the antiphospholipid antibody syndrome. Wesemann, D. R.; Costenbader, K. H.; Coblyn, J. S. // Lupus;Mar2009, Vol. 18 Issue 3, p202 

    Sarcoidosis, systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APS) are chronic conditions of immune dysregulation whose aetiologies remain mysterious. Expression of sarcoidosis and SLE within individuals has been reported in a handful of cases in the last 60 years. In...

  • The Ped-APS Registry: the antiphospholipid syndrome in childhood. Avcin, T.; Cimaz, R.; Rozman, B. // Lupus;Sep2009, Vol. 18 Issue 10, p894 

    In recent years, antiphospholipid syndrome (APS) has been increasingly recognised in various paediatric autoimmune and nonautoimmune diseases, but the relatively low prevalence and heterogeneity of APS in childhood made it very difficult to study in a systematic way. The project of an...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics